scholarly journals The study of Health Care Utilization and Direct Medical Cost in the Diabetes Mellitus Client

2015 ◽  
Vol 1 (4) ◽  
pp. 87-101 ◽  
Author(s):  
In Sook Yoo
Keyword(s):  
Diabetes Mellitus ◽  
Health Care ◽  
Health Care Utilization ◽  
Direct Medical Cost ◽  
Medical Cost ◽  
Care Utilization

Frailty and Health Care Utilization among Community-Dwelling Older Patients with Diabetes Mellitus

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1468-P
Author(s):  
SHIVANI PRIYADARSHNI ◽  
SRUTHI NELLURI ◽  
ZUBAIR RAHAMAN ◽  
MICHAEL J. MINTZER ◽  
STUTI DANG ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Health Care ◽  
Health Care Utilization ◽  
Older Patients ◽  
Community Dwelling ◽  
Care Utilization ◽  
Patients With Diabetes

Health Care Utilization and Medical Cost Outcomes from a Digital Diabetes Prevention Program in a Medicare Advantage Population

2020 ◽  
Vol 23 (6) ◽  
pp. 414-421
Author(s):  
Douglas Barthold ◽  
Vinay Chiguluri ◽  
Rajiv Gumpina ◽  
Cynthia Castro Sweet ◽  
Jason Pieratt ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Medical Cost ◽  
Prevention Program ◽  
Diabetes Prevention ◽  
Diabetes Prevention Program ◽  
Care Utilization ◽  
Medicare Advantage ◽  
Cost Outcomes

scholarly journals Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus

2019 ◽  
Vol 3 (21) ◽  
pp. 3297-3306
Author(s):  
Sherif M. Badawy ◽  
Amanda B. Payne
Keyword(s):  
Diabetes Mellitus ◽  
Health Care ◽  
Sickle Cell Disease ◽  
Health Care Utilization ◽  
Clinical Outcomes ◽  
Care Utilization ◽  
Cell Disease ◽  
Clinical Events ◽  
Key Points ◽  
Clinical Benefits

Key Points Metformin use was associated with significantly fewer SCD-related health care utilization encounters and clinical events. Our findings provide the first evidence to suggest potential clinical benefits associated with metformin use in patients with SCD.

Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus

2007 ◽  
Vol 29 (6) ◽  
pp. 1306-1315 ◽  
Author(s):  
Rajesh Balkrishnan ◽  
Bhakti V. Arondekar ◽  
Fabian T. Camacho ◽  
Rahul A. Shenolikar ◽  
Ruslan Horblyuk ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Health Care ◽  
Type 2 Diabetes Mellitus ◽  
Health Care Utilization ◽  
Care Utilization

Are Inflammatory Bowel Disease Patients With Diabetes Mellitus at Increased Risk for Poor Outcomes Including Greater Health Care Utilization?

2020 ◽  
Vol 26 (9) ◽  
pp. 1443-1444
Author(s):  
Uni Wong ◽  
Raymond K Cross
Keyword(s):  
Diabetes Mellitus ◽  
Health Care ◽  
Inflammatory Bowel Disease ◽  
Health Care Utilization ◽  
Bowel Disease ◽  
Care Utilization ◽  
Increased Risk ◽  
Patients With Diabetes ◽  
Inflammatory Bowel ◽  
Active Disease

Inflammatory bowel disease patients with diabetes mellitus are more likely to have active disease, report worse quality of life, and have higher health care utilization. This high-risk subgroup of patients with confirmed active disease should be treated with appropriate medical therapy including biologic therapy with or without an immunosuppressant.

Sign in / Sign up

Export Citation Format

Share Document